UncategorizedAllogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma TranscriptPost Content admin9460April 13, 2026
UncategorizedThe Goldman Sachs Group, Inc. (GS) Q1 2026 Earnings Call TranscriptPost Content admin9460April 13, 2026
UncategorizedCoreWeave: Unjustified AI Bubble Fears; Buy Signals Are Finally Flashing (Rating Upgrade)Post Content admin9460April 12, 2026
UncategorizedAttractive Setup In Fallen Angels: 7% Yield And New DowngradesPost Content admin9460April 12, 2026
UncategorizedAT&T: Locking In A Fixed Yield Ahead Of Large Investment CyclePost Content admin9460April 12, 2026
UncategorizedWhen No One Shows Up, Opportunity Does: The Office REIT ResetPost Content admin9460April 12, 2026
UncategorizedRedwire: A Speculative Buy Upgrade In A Red-Hot Space MarketPost Content admin9460April 12, 2026
UncategorizedThe Only Dividend Strategy I’d Trust In A 3.5% Fed Funds WorldPost Content admin9460April 11, 2026
UncategorizedOpera: AI-Driven Advertising Prospects – Upside Potential And Rich Dividend YieldsPost Content admin9460April 11, 2026